PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
Dicyclohexyl phthalate
EC / List no: 201-545-9 CAS no: 84-61-7
DEv 1
| Scope | Targeted |
| Status | Information requested |
| Decision date | 23-jan-2024 |
| Decision | |
| Latest update | 22-mrt-2024 |
| Additional information | |
| More information |  |
CCH-D-2114667462-44-01/F
DEv 2
| Scope | Comprehensive |
| Status | Concluded |
| Decision date | |
| Decision | |
| Latest update | 26-nov-2022 |
| Additional information | ECHA has performed an assessment and did not issue a decision. |
| More information | |
SEv 1
| Evaluating Member State | Sweden |
| Co-Evaluating Member State | |
| Initial grounds for concern | Potential endocrine disruptor Exposure of environment Wide dispersive use |
| Year | 2017 |
| Status | Concluded |
| Conclusion document | |
| Latest update | 24-aug-2023 |
| More information | |
ED 1
| Authority | Sweden |
| Status | Concluded |
| Outcome | ED ENV |
| Hazard assessment outcome document | |
| Remarks | The substance has been identified as SVHC due to its ED HH properties. The SHVC proposal for ED ENV was withdrawn because the existing data concerning potential endocrine disrupting effects was considered not sufficient to conclude/agree that DCHP has endocrine disrupting properties for which there is evidence of probable serious adverse effects to the environment giving rise to equivalent level of concern. |
| Concern | Endocrine disruption |
| Date of intention | 14-sep-2020 |
| Date of hazard assessment | 24-aug-2023 |
| Latest update | 04-okt-2023 |
| More information | |
ED 2
| Authority | Sweden |
| Status | Concluded |
| Outcome | ED HH |
| Hazard assessment outcome document | |
| Remarks | Identified as SVHC in accordance with Article 57(f) of REACH due to its endocrine disrupting properties with probable serious effects to human health and in accordance with Article 57(c) of REACH due to its harmonised classification as toxic for reproduction category 1B under CLP. |
| Concern | Endocrine disruption |
| Date of intention | 20-mrt-2015 |
| Date of hazard assessment | 27-jun-2018 |
| Latest update | 03-feb-2021 |
| More information | |
CLH 1
| Status | Opinion Adopted |
| Date of intention | 12-feb-2013 |
| Withdrawal date | |
| Submitter | Sweden |
| Proposed harmonised classification by the dossier submitter | Skin Sens. 1, H317 Repr. 1B, H360FD |
| Remarks | |
| Date of opinion | 04-dec-2014 |
| RAC Opinion | |
| Latest update | 02-apr-2019 |
| More information | |
SVHC 1
| Status | Identified SVHC |
| Date of intention | 20-mrt-2015 |
| Withdrawal date | |
| Submitter | Sweden |
| Remarks | |
| Scope | Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
| Date of inclusion in Candidate List | 27-jun-2018 |
| Latest update | 07-dec-2021 |
| More information | |
Recom 1
| Intrinsic property | Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
| Status | Recommended for inclusion in Annex XIV |
| Recommendation round | 10th recommendation |
| Date of draft recommendation | 05-mrt-2020 |
| Date of final recommendation | 14-apr-2021 |
| Final recommendation | |
| Date of inclusion in Authorisation List | |
| Regulation amending Annex XIV | |
| Remarks | |
| More information | |
ARN 1
| Authority | ECHA |
| Concern | |
| Status | Under development |
| Follow-up | CCH |
| Foreseen regulatory need | Annex XIV Restriction |
| Summary document | |
| Group name | Ortho-phthalates |
| Remarks | |
| Date of intention | 01-mrt-2020 |
| Date of assessment | 21-jun-2021 |
| Latest update | 07-dec-2021 |
| More information | |
ARN 2
| Authority | Sweden |
| Concern | Endocrine disruption |
| Status | Concluded |
| Follow-up | SVHC |
| Foreseen regulatory need | |
| Summary document | |
| Group name | |
| Remarks | |
| Date of intention | 20-mrt-2015 |
| Date of assessment | 07-sep-2015 |
| Latest update | 24-nov-2021 |
| More information | |
List entry date: 21-mrt-2017